28.08
price down icon0.57%   -0.16
after-market Handel nachbörslich: 28.00 -0.08 -0.28%
loading

Genmab Adr Aktie (GMAB) Neueste Nachrichten

pulisher
Sep 16, 2025

Foresight Group Ltd Liability Partnership Takes Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Vident Advisory LLC Buys Shares of 12,377 Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 16, 2025
pulisher
Sep 15, 2025

Scientech Research LLC Increases Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

Genmab A/S (NASDAQ:GMAB) Sets New 1-Year HighStill a Buy? - MarketBeat

Sep 14, 2025
pulisher
Sep 10, 2025

Northern Trust Corp Raises Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 10, 2025
pulisher
Sep 09, 2025

Genmab A/S Sponsored ADR $GMAB Shares Sold by Alliancebernstein L.P. - MarketBeat

Sep 09, 2025
pulisher
Sep 09, 2025

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewswire Inc.

Sep 09, 2025
pulisher
Sep 08, 2025

Graham Capital Management L.P. Acquires 16,035 Shares of Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 08, 2025
pulisher
Sep 05, 2025

Cubist Systematic Strategies LLC Grows Holdings in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 05, 2025
pulisher
Sep 04, 2025

Orbis Allan Gray Ltd Has $111.82 Million Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 04, 2025
pulisher
Sep 03, 2025

Synovus Financial Corp Takes $633,000 Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 03, 2025
pulisher
Sep 02, 2025

Tema Etfs LLC Boosts Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 02, 2025
pulisher
Sep 01, 2025

Cresset Asset Management LLC Has $244,000 Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 01, 2025
pulisher
Aug 27, 2025

Cresset Asset Management LLC Has $244,000 Stock Position in Genmab A/S Sponsored ADR $GMAB - Defense World

Aug 27, 2025
pulisher
Aug 27, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Aug 27, 2025
pulisher
Aug 22, 2025

Genmab A/S (NASDAQ:GMAB) Cut to Hold at Zacks Research - Defense World

Aug 22, 2025
pulisher
Aug 21, 2025

IBD Rating Upgrades: MINISO Group Holding ADR Flashes Improved Technical Strength - inkl

Aug 21, 2025
pulisher
Aug 20, 2025

IBD Rating Upgrades: Genmab ADR Shows Improved Relative Price Strength - Investor's Business Daily

Aug 20, 2025
pulisher
Aug 19, 2025

Biotech Stocks To Watch And Pharma Industry News - Investor's Business Daily

Aug 19, 2025
pulisher
Aug 19, 2025

IBD Rating Upgrades: Applied Indl Techs Shows Improved Relative Price Strength - inkl

Aug 19, 2025
pulisher
Aug 18, 2025

What is HC Wainwright’s Forecast for Genmab A/S Q1 Earnings? - Defense World

Aug 18, 2025
pulisher
Aug 18, 2025

IBD Rating Upgrades: HCA Healthcare Shows Improved Technical Strength - inkl

Aug 18, 2025
pulisher
Aug 15, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Shares Purchased by LPL Financial LLC - Defense World

Aug 15, 2025
pulisher
Aug 11, 2025

What is William Blair’s Forecast for Genmab A/S Q3 Earnings? - Defense World

Aug 11, 2025
pulisher
Aug 09, 2025

Wall Street Analysts Believe Genmab (GMAB) Could Rally 33.8%: Here's is How to Trade - MSN

Aug 09, 2025
pulisher
Aug 08, 2025

Genmab and BioNTech’s Innovative Cancer Trial: A Market Game Changer? - The Globe and Mail

Aug 08, 2025
pulisher
Aug 08, 2025

BioNTech and Genmab’s Promising Colorectal Cancer Study: A Potential Game-Changer? - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

GMAB: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com

Aug 07, 2025
pulisher
Aug 07, 2025

Genmab and BioNTech’s Promising Cancer Study: A Potential Game-Changer? - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Genmab and BioNTech’s GEN1042 Study: A Potential Game-Changer in Cancer Treatment - TipRanks

Aug 07, 2025
pulisher
Aug 06, 2025

Genmab and BioNTech’s Innovative Cancer Trial: A Potential Game-Changer? - The Globe and Mail

Aug 06, 2025
pulisher
Aug 06, 2025

Genmab and BioNTech SE’s GEN1056 Study: A New Hope for Advanced Solid Tumors - The Globe and Mail

Aug 06, 2025
pulisher
Jul 24, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Stake Lessened by Cerity Partners LLC - Defense World

Jul 24, 2025
pulisher
Jul 24, 2025

Genmab and BioNTech Launch Promising Study for Advanced Colorectal Cancer Treatment - The Globe and Mail

Jul 24, 2025
pulisher
Jul 23, 2025

Genmab (GMAB) Upgraded to Strong Buy: Here's Why - MSN

Jul 23, 2025
pulisher
Jul 22, 2025

Wall Street Analysts See a 39.97% Upside in Genmab (GMAB): Can the Stock Really Move This High? - Zacks Investment Research

Jul 22, 2025
pulisher
Jul 19, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Shares Purchased by Envestnet Asset Management Inc. - Defense World

Jul 19, 2025
pulisher
Jul 17, 2025

Genmab Bets On Antibody Innovations As Royalties Rule The Day - Finimize

Jul 17, 2025
$84.80
price up icon 1.07%
$35.64
price up icon 0.62%
$98.15
price down icon 1.12%
$144.78
price up icon 0.02%
biotechnology ONC
$332.20
price up icon 1.53%
Kapitalisierung:     |  Volumen (24h):